Effect of a Default Order vs an Alert in the Electronic Health Record on Hepatitis C Virus Screening Among Hospitalized Patients: A Stepped-Wedge Randomized Clinical Trial

Shivan J Mehta, Jessie Torgersen, Dylan S Small, Colleen P Mallozzi, John D McGreevey 3rd, Charles A L Rareshide, Chalanda N Evans, Mika Epps, David Stabile, Christopher K Snider, Mitesh S Patel, Shivan J Mehta, Jessie Torgersen, Dylan S Small, Colleen P Mallozzi, John D McGreevey 3rd, Charles A L Rareshide, Chalanda N Evans, Mika Epps, David Stabile, Christopher K Snider, Mitesh S Patel

Abstract

Importance: Hepatitis C virus (HCV) screening has been recommended for patients born between 1945 and 1965, but rates remain low.

Objective: To evaluate whether a default order within the admission order set increases HCV screening compared with a preexisting alert within the electronic health record.

Design, setting, and participants: This stepped-wedge randomized clinical trial was conducted from June 23, 2020, to April 10, 2021, at 2 hospitals within an academic medical center. Hospitalized patients born between 1945 and 1965 with no history of screening were included in the analysis.

Interventions: During wedge 1 (a preintervention period), both hospital sites had an electronic alert prompting clinicians to consider HCV screening. During wedge 2, the first intervention wedge, the hospital site randomized to intervention (hospital B) had a default order for HCV screening implemented within the admission order set. During wedge 3, the second intervention wedge, the hospital site randomized to control (hospital A) had the default order set implemented.

Main outcomes and measures: Percentage of eligible patients who received HCV screening during the hospital stay.

Results: The study included 7634 patients (4405 in the control group and 3229 in the intervention group). The mean (SD) age was 65.4 (5.8) years; 4246 patients (55.6%) were men; 2142 (28.1%) were Black and 4625 (60.6%) were White; and 2885 (37.8%) had commercial insurance and 3950 (51.7%) had Medicare. The baseline rate of HCV screening in wedge 1 was 585 of 1560 patients (37.5% [95% CI, 35.1%-40.0%]) in hospital A and 309 of 1003 patients (30.8% [95% CI, 27.9%-33.7%]) in hospital B. The main adjusted model showed an increase of 31.8 (95% CI, 29.7-33.8) percentage points in test completion in the intervention group compared with the control group (P <. 001).

Conclusions and relevance: This stepped-wedge randomized clinical trial found that embedding HCV screening as a default order in the electronic health record substantially increased ordering and completion of testing in the hospital compared with a conventional interruptive alert.

Trial registration: Clinicaltrials.gov: NCT04525690.

Conflict of interest statement

Conflict of Interest Disclosures: Dr Mehta reported receiving grants from the National Cancer Institute outside the submitted work and receiving an honorarium from the American Gastroenterological Association. Dr Patel reported being a founder of Catalyst Health Group, a technology and behavior change consulting firm; and serving on the medical advisory boards for Healthmine, Inc, Life.io, and Holistic Industries. Dr Patel reported receiving personal fees as owner of Catalyst Health Group and serving on the advisory board for Humana Inc outside the submitted work. No other disclosures were reported.

Figures

Figure 1.. Study Flow Diagram
Figure 1.. Study Flow Diagram
Each hospital participated in 3 wedges: wedge 1 (a preintervention period), wedge 2 (intervention in hospital B vs control in hospital A), and wedge 3 (intervention in both hospitals).
Figure 2.. Hepatitis C Virus Screening Completion…
Figure 2.. Hepatitis C Virus Screening Completion by Hospital Site and Study Month
Wedge 1 was a preintervention period. Hospital A (control hospital) received the intervention during wedge 3; hospital B received the intervention during wedges 2 and 3.

References

    1. Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. Gastroenterology. 2015;149(6):1471-1482.e5. doi:10.1053/j.gastro.2015.07.056
    1. de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015;62(4):1190-1200. doi:10.1002/hep.27969
    1. Afdhal N, Zeuzem S, Kwo P, et al. ; ION-1 Investigators . Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014;370(20):1889-1898. doi:10.1056/NEJMoa1402454
    1. Feld JJ, Jacobson IM, Hézode C, et al. ; ASTRAL-1 Investigators . Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 Infection. N Engl J Med. 2015;373(27):2599-2607. doi:10.1056/NEJMoa1512610
    1. Moyer VA; U.S. Preventive Services Task Force . Screening for hepatitis C virus infection in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159(5):349-357. doi:10.7326/0003-4819-159-5-201309030-00672
    1. Smith BD, Morgan RL, Beckett GA, et al. ; Centers for Disease Control and Prevention . Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61(RR-4):1-32.
    1. Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis C screening among adults—United States, 2020. MMWR Recomm Rep. 2020;69(2):1-17. doi:10.15585/mmwr.rr6902a1
    1. Owens DK, Davidson KW, Krist AH, et al. ; US Preventive Services Task Force . Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement. JAMA. 2020;323(10):970-975. doi:10.1001/jama.2020.1123
    1. Jemal A, Fedewa SA. Recent hepatitis C virus testing patterns among Baby Boomers. Am J Prev Med. 2017;53(1):e31-e33. doi:10.1016/j.amepre.2017.01.033
    1. Kasting ML, Giuliano AR, Reich RR, et al. . Hepatitis C virus screening trends: serial cross-sectional analysis of the National Health Interview Survey population, 2013-2015. Cancer Epidemiol Biomarkers Prev. 2018;27(4):503-513. doi:10.1158/1055-9965.EPI-17-0855
    1. Flanigan CA, Leung SJ, Rowe KA, et al. . Evaluation of the impact of mandating health care providers to offer hepatitis C virus screening to all persons born during 1945-1965—New York, 2014. MMWR Morb Mortal Wkly Rep. 2017;66(38):1023-1026. doi:10.15585/mmwr.mm6638a3
    1. Pennsylvania General Assembly. Hepatitis C Screening Act–Enactment. PL 787, No. 87. Posted July 20, 2016. Accessed February 14, 2022.
    1. Kahneman D, Knetsch JL, Thaler RH. Anomalies: the endowment effect, loss aversion, and status quo bias. J Econ Perspect . 1991;5(1):193-206. doi:10.1257/jep.5.1.193
    1. Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185(4157):1124-1131. doi:10.1126/science.185.4157.1124
    1. Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298(20):2415-2417. doi:10.1001/jama.298.20.2415
    1. Mehta SJ, Asch DA. How to help gastroenterology patients help themselves: leveraging insights from behavioral economics. Clin Gastroenterol Hepatol. 2014;12(5):711-714. doi:10.1016/j.cgh.2014.02.022
    1. Patel MS, Day SC, Halpern SD, et al. . Generic medication prescription rates after health system-wide redesign of default options within the electronic health record. JAMA Intern Med. 2016;176(6):847-848. doi:10.1001/jamainternmed.2016.1691
    1. Hsiang EY, Mehta SJ, Small DS, et al. . Association of an active choice intervention in the electronic health record directed to medical assistants with clinician ordering and patient completion of breast and colorectal cancer screening tests. JAMA Netw Open. 2019;2(11):e1915619. doi:10.1001/jamanetworkopen.2019.15619
    1. Sharma S, Guttmann D, Small DS, et al. . Effect of introducing a default order in the electronic medical record on unnecessary daily imaging during palliative radiotherapy for adults with cancer: a stepped-wedge cluster randomized clinical trial. JAMA Oncol. 2019;5(8):1220-1222. doi:10.1001/jamaoncol.2019.1432
    1. Patel MS, Volpp KG, Asch DA. Nudge units to improve the delivery of health care. N Engl J Med. 2018;378(3):214-216. doi:10.1056/NEJMp1712984
    1. Asch DA, Ziolek TA, Mehta SJ. Misdirections in informed consent—impediments to health care innovation. N Engl J Med. 2017;377(15):1412-1414. doi:10.1056/NEJMp1707991
    1. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182-191. doi:10.1016/j.cct.2006.05.007
    1. Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350:h391. doi:10.1136/bmj.h391
    1. Sedrak MS, Myers JS, Small DS, et al. . Effect of a price transparency intervention in the electronic health record on clinician ordering of inpatient laboratory tests: the PRICE randomized clinical trial. JAMA Intern Med. 2017;177(7):939-945. doi:10.1001/jamainternmed.2017.1144
    1. Yartel AK, Rein DB, Brown KA, et al. . Hepatitis C virus testing for case identification in persons born during 1945-1965: results from three randomized controlled trials. Hepatology. 2018;67(2):524-533. doi:10.1002/hep.29548
    1. Manz CR, Parikh RB, Small DS, et al. . Effect of integrating machine learning mortality estimates with behavioral nudges to clinicians on serious illness conversations among patients with cancer: a stepped-wedge cluster randomized clinical trial. JAMA Oncol. 2020;6(12):e204759. doi:10.1001/jamaoncol.2020.4759
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. doi:10.1016/0021-9681(87)90171-8
    1. Setiawan VW, Stram DO, Porcel J, Lu SC, Le Marchand L, Noureddin M. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort. Hepatology. 2016;64(6):1969-1977. doi:10.1002/hep.28677
    1. Efron B, Tibshirani R. An Introduction to the Bootstrap. Chapman & Hall; 1993.
    1. Davison AC, Hinkley DV. Bootstrap Methods and Their Application. Cambridge University Press; 1997.
    1. Bates DW, Kuperman GJ, Wang S, et al. . Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc. 2003;10(6):523-530. doi:10.1197/jamia.M1370
    1. Teich JM, Merchia PR, Schmiz JL, Kuperman GJ, Spurr CD, Bates DW. Effects of computerized physician order entry on prescribing practices. Arch Intern Med. 2000;160(18):2741-2747. doi:10.1001/archinte.160.18.2741
    1. Chertow GM, Lee J, Kuperman GJ, et al. . Guided medication dosing for inpatients with renal insufficiency. JAMA. 2001;286(22):2839-2844. doi:10.1001/jama.286.22.2839
    1. McGreevey JD III, Mallozzi CP, Perkins RM, Shelov E, Schreiber R. Reducing alert burden in electronic health records: state of the art recommendations from four health systems. Appl Clin Inform. 2020;11(1):1-12. doi:10.1055/s-0039-3402715
    1. Fihn SD. Making measurement matter. JAMA Netw Open. 2018;1(3):e180843-e180843. doi:10.1001/jamanetworkopen.2018.0843
    1. Mehta SJ, Day SC, Norris AH, et al. . Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial. BMJ. 2021;373:n1022. doi:10.1136/bmj.n1022

Source: PubMed

3
Prenumerera